116 related articles for article (PubMed ID: 18241279)
1. Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis.
Tominaga M; Ogawa H; Takamori K
Br J Dermatol; 2008 Apr; 158(4):842-4. PubMed ID: 18241279
[No Abstract] [Full Text] [Related]
2. Aberrant epidermal expression of semaphorin 3A and nerve growth factor in prurigo nodularis.
Takada S; Kou K; Nagashima Y; Ikezawa Z; Aihara M
J Dermatol; 2013 May; 40(5):404-6. PubMed ID: 23398122
[No Abstract] [Full Text] [Related]
3. Co-stimulation with interleukin-4 and tumor necrosis factor-α increases epidermal innervation accompanied by suppression of semaphorin 3A.
Sakai T; Takahashi D; Nikaido K; Okauchi K; Mori N; Irie R; Hatano Y; Fujiwara S
J Dermatol Sci; 2014 Oct; 76(1):69-71. PubMed ID: 25088775
[No Abstract] [Full Text] [Related]
4. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis.
Tominaga M; Tengara S; Kamo A; Ogawa H; Takamori K
J Dermatol Sci; 2009 Jul; 55(1):40-6. PubMed ID: 19443185
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of UV-based therapy on dry skin-inducible nerve growth in acetone-treated mice.
Kamo A; Tominaga M; Tengara S; Ogawa H; Takamori K
J Dermatol Sci; 2011 May; 62(2):91-7. PubMed ID: 21458246
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
[TBL] [Abstract][Full Text] [Related]
7. Expression of Neuropeptides, Neurotrophins, and Neurotransmitters in the Skin of Patients with Atopic Dermatitis and Psoriasis.
Kubanov AA; Katunina OR; Chikin VV
Bull Exp Biol Med; 2015 Jul; 159(3):318-22. PubMed ID: 26201903
[TBL] [Abstract][Full Text] [Related]
8. Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis.
Kim HO; Lee CH; Ahn HK; Park CW
Int J Dermatol; 2009 Apr; 48(4):431-8. PubMed ID: 19335435
[TBL] [Abstract][Full Text] [Related]
9. Enhanced production and secretion of glial cell line-derived neurotrophic factor and nerve growth factor from the skin in atopic dermatitis mouse model.
Tokime K; Katoh-Semba R; Yamanaka K; Mizoguchi A; Mizutani H
Arch Dermatol Res; 2008 Aug; 300(7):343-52. PubMed ID: 18443810
[TBL] [Abstract][Full Text] [Related]
10. Modulation of semaphorin 3A expression by calcium concentration and histamine in human keratinocytes and fibroblasts.
Fukamachi S; Bito T; Shiraishi N; Kobayashi M; Kabashima K; Nakamura M; Tokura Y
J Dermatol Sci; 2011 Feb; 61(2):118-23. PubMed ID: 21176873
[TBL] [Abstract][Full Text] [Related]
11. A hypothetical mechanism of intraepidermal neurite formation in NC/Nga mice with atopic dermatitis.
Tominaga M; Ozawa S; Ogawa H; Takamori K
J Dermatol Sci; 2007 Jun; 46(3):199-210. PubMed ID: 17350228
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide modulates the expression of axon-guidance molecules in human keratinocytes.
Moniaga CS; Kamata Y; Ogawa H; Suga Y; Tominaga M; Takamori K
J Dermatol Sci; 2020 Mar; 97(3):232-235. PubMed ID: 32035842
[No Abstract] [Full Text] [Related]
13. Neurotropin inhibits the increase in intraepidermal nerve density in the acetone-treated dry-skin mouse model.
Kamo A; Tominaga M; Taneda K; Ogawa H; Takamori K
Clin Exp Dermatol; 2013 Aug; 38(6):665-8. PubMed ID: 23745989
[TBL] [Abstract][Full Text] [Related]
14. Altered cutaneous expression of beta-defensins in dogs with atopic dermatitis.
van Damme CM; Willemse T; van Dijk A; Haagsman HP; Veldhuizen EJ
Mol Immunol; 2009 Aug; 46(13):2449-55. PubMed ID: 19576634
[TBL] [Abstract][Full Text] [Related]
15. Aberrant suprabasal P-cadherin expression in acanthotic but not psoriatic thickened epidermis.
Wakita H; Yamamoto Y; Furukawa F
Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S71-4. PubMed ID: 12677438
[No Abstract] [Full Text] [Related]
16. Possible role of nerve growth factor and interleukin-18 in pathogenesis of eczematous lesions of atopic dermatitis.
Shaker OG; El-Komy M; Tawfic SO; Zeidan N; Tomairek RH
J Dermatol Sci; 2009 Feb; 53(2):153-4. PubMed ID: 18922682
[No Abstract] [Full Text] [Related]
17. Effect of the phosphodiesterase 4 inhibitor E6005 on nerve growth factor elevation in irritated skin of NC/Nga mice.
Ishii N; Wakita H; Shirato M
J Dermatol Sci; 2014 Dec; 76(3):263-4. PubMed ID: 25455141
[No Abstract] [Full Text] [Related]
18. Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs.
Piekutowska A; Pin D; Rème CA; Gatto H; Haftek M
J Comp Pathol; 2008 May; 138(4):197-203. PubMed ID: 18374938
[TBL] [Abstract][Full Text] [Related]
19. Proliferative processes in the epidermis of patients with atopic dermatitis treated with thymodepressin.
Sapuntsova SG; Mel'nikova NP; Deigin VI; Kozulin EA; Timoshin SS
Bull Exp Biol Med; 2002 May; 133(5):488-90. PubMed ID: 12420069
[TBL] [Abstract][Full Text] [Related]
20. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
